Axon Enterprise, Inc. AAXN
Set alert
No live quote for AAXN yet.
- Open
- 173.46
- Prev close
- 170.26
- Mkt cap
- 11.09B
- Vol
- 609.61K
- Avg vol
- 627.87K
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 168.19
- High
- 177.43
- Forward P/E
- 134.26
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 162.81
- 200-d avg
- 118.47
- 1y target
- 129.50
Analyst view
Consensus: buy
Buy
Price target (mean) 129.50
- Target (low)
- 92.00
- Target (mean)
- 129.50
- Target (high)
- 185.00
Ratings (0m) 9 6 buy · 3 hold · 0 sell
- Strong buy2
- Buy4
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 13
- 2 months ago 13
- 3 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.35 | 0.26 – 0.43 | 0.41 | -14.6% | 181.03M | +5.3% | 11 |
| Next quarter | 0.27 | 0.16 – 0.38 | 0.40 | -32.5% | 171.09M | 0.0% | 9 |
| Current year | 1.11 | 0.80 – 1.23 | 1.04 | +6.7% | 636.59M | +19.9% | 10 |
| Next year | 1.30 | 0.86 – 1.54 | 1.11 | +17.1% | 741.08M | +16.4% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 12, 2021 | JP Morgan | Downgrade | Overweight | Neutral |
| Feb 1, 2021 | Morgan Stanley | Initiated | — | Overweight |
| Jan 15, 2021 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Dec 16, 2020 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Nov 6, 2020 | Morgan Stanley | Maintained | — | Equal-Weight |
| Nov 6, 2020 | Needham | Maintained | — | Buy |
| Aug 7, 2020 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jul 20, 2020 | Needham | Maintained | — | Buy |
| May 18, 2020 | Imperial Capital | Maintained | — | In-Line |
| May 11, 2020 | JMP Securities | Reiterated | — | Market Outperform |
| May 5, 2020 | Morgan Stanley | Maintained | — | Equal-Weight |
| Mar 17, 2020 | Morgan Stanley | Maintained | — | Equal-Weight |
| Mar 2, 2020 | Imperial Capital | Downgrade | Outperform | In-Line |
| Feb 28, 2020 | Baird | Maintained | — | Outperform |
| Feb 28, 2020 | Needham | Maintained | — | Buy |
| Feb 24, 2020 | JP Morgan | Maintained | — | Overweight |
| Feb 20, 2020 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jan 6, 2020 | Needham | Maintained | — | Buy |
| Dec 10, 2019 | JMP Securities | Initiated | — | Market Outperform |
| Nov 27, 2019 | Raymond James | Downgrade | Strong Buy | Market Perform |
| Nov 26, 2019 | Morgan Stanley | Maintained | — | Overweight |
| Nov 12, 2019 | Imperial Capital | Maintained | — | Outperform |
| Nov 8, 2019 | Needham | Upgrade | Hold | Buy |
| Aug 14, 2019 | Imperial Capital | Upgrade | In-Line | Outperform |
| Aug 9, 2019 | Needham | Downgrade | Buy | Hold |
| May 24, 2019 | Imperial Capital | Downgrade | Outperform | In-Line |
| Apr 8, 2019 | Raymond James | Upgrade | Outperform | Strong Buy |
| Jan 7, 2019 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 9, 2018 | Baird | Upgrade | Neutral | Outperform |
| Nov 8, 2018 | JP Morgan | Upgrade | Neutral | Overweight |